Bookmark and Share
glycogen synthase kinase-3 alpha [Homo sapien.. [gi:49574532] - Target BioActivity Data
Also known as: glycogen synthase kinase-3 alpha [Homo sapiens].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(1145)
 
 
BioAssay Types:
Confirmatory(827)
 
 
Screening(318)
 
 
BioActivity Types:
AC50(827)
 
 
Substance Types:
Chemical(1145)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 5    Data Row: 1145   Total Pages: 58   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID49674818]
[CID11405589]
AC50_uM 0.0135Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
2
[SID49674819]
[CID176158]
AC50_uM 0.02Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
3
[SID103023249]
[CID661958]
AC50_uM 0.0218Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
4
[SID103023240]
[CID9558362]
AC50_uM 0.0219Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
5
[SID103023235]
[CID46500289]
AC50_uM 0.0392Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
6
[SID74374076]
[CID53313071]
AC50_uM 0.105Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
7
[SID104170299]
[CID6539118]
AC50_uM 0.121Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
8
[SID104170299]
[CID6539118]
AC50_uM 0.144Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
9
[SID103023211]
[CID936046]
AC50_uM 0.168Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
10
[SID87219187]
[CID6539118]
AC50_uM 0.206Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
11
[SID859474]
[CID660775]
AC50_uM 0.2109Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
12
[SID859094]
[CID660396]
AC50_uM 0.2344Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
13
[SID49820366]
[CID5927014]
AC50_uM 0.2431Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
14
[SID103023202]
[CID3294594]
AC50_uM 0.276Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
15
[SID87219187]
[CID6539118]
AC50_uM 0.281Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
16
[SID103023243]
[CID660516]
AC50_uM 0.288Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
17
[SID49641385]
[CID3163532]
AC50_uM 0.3121Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha [AID463203, Type: confirmatory]
View
18
[SID103023246]
[CID10114110]
AC50_uM 0.361Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2 [AID623978, Type: confirmatory]
View
19
[SID103023248]
[CID5727763]
AC50_uM 0.367Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2 [AID588434, Type: confirmatory]
View
20
[SID124360055]
[CID3541811]
AC50_uM 0.388Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity [AID588361, Type: confirmatory]
View